Literature DB >> 20546160

Sevoflurane for central catheter placement in neonatal intensive care: a randomized trial.

Fabrice Michel1, Renaud Vialet, Sophie Hassid, Claire Nicaise, Aurélie Garbi, Laurent Thomachot, Jean N DI Marco, Pierre Lagier, Claude Martin.   

Abstract

OBJECTIVE: To compare the efficacy and safety of sevoflurane deep sedation with glucose and nonnutritive sucking (GNNS) in reducing the duration of the procedure and in preventing pain-related effects during peripherally inserted central catheter (PICC) placement.
BACKGROUND: PICC placement in neonatal intensive care is a delicate and stressful procedure that requires pain prevention. GNNS has been recommended in this situation but remain often inefficient.
METHODS: We designed a randomized controlled study in a sixteen-bed pediatric and neonatal unit in a tertiary hospital. Fifty-nine neonates at >28 weeks of gestation with continuous positive airway pressure or invasive mechanical ventilation and requiring PICC placement were included. Patients were randomized to receive inhaled sevoflurane (IS) or glucose and non-nutritive sucking (GNNS). Procedural duration and conditions, hemodynamic and respiratory parameters, occurrence of movements and complications were compared (http://clinicaltrials.gov trial register no. NCT00420693).
RESULTS: The two groups had similar demographics. There were no between-group differences in procedural duration (P = 0.84) despite greater immobility in IS group (P = 0.017). IS was also associated with fewer episodes of hypertension (P = 0.003), tachycardia (P < 0.001), and bradycardia (P = 0.02). Occurrences of hypotension were not different between the groups (P = 0.06). The GNNS group showed more desaturation during the 4 h after the procedure (P = 0.03). Complications during intensive care stay did not differ between groups.
CONCLUSION: Inhaled sevoflurane does not make easier catheters placement but prevent pain-related symptoms. Because sevoflurane is responsible for hypotension, it requires careful monitoring and treatment adaptation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546160     DOI: 10.1111/j.1460-9592.2010.03334.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  7 in total

Review 1.  A systematic review and meta-analyses of nonsucrose sweet solutions for pain relief in neonates.

Authors:  Mariana Bueno; Janet Yamada; Denise Harrison; Sobia Khan; Arne Ohlsson; Thomasin Adams-Webber; Joseph Beyene; Bonnie Stevens
Journal:  Pain Res Manag       Date:  2013 May-Jun       Impact factor: 3.037

2.  Nutritional strategies and gut microbiota composition as risk factors for necrotizing enterocolitis in very-preterm infants.

Authors:  Jean-Christophe Rozé; Pierre-Yves Ancel; Patricia Lepage; Laetitia Martin-Marchand; Ziad Al Nabhani; Johanne Delannoy; Jean-Charles Picaud; Alexandre Lapillonne; Julio Aires; Mélanie Durox; Dominique Darmaun; Josef Neu; Marie-José Butel; Clement Chollat
Journal:  Am J Clin Nutr       Date:  2017-06-28       Impact factor: 7.045

3.  Effect of a bolus dose of fentanyl on the ED₅₀ and ED₉₅ of sevoflurane in neonates.

Authors:  Ying-Jun She; Huai-Zhen Wang; Jun-Xiang Huang; Yong-Hong Tan; Zi-Xing Wang; Hang Tian; Xing-Rong Song
Journal:  Med Sci Monit       Date:  2014-12-14

Review 4.  Randomized controlled trials in central vascular access devices: A scoping review.

Authors:  Mari Takashima; Gillian Ray-Barruel; Amanda Ullman; Samantha Keogh; Claire M Rickard
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

5.  Does sevoflurane add to outpatient procedural sedation in children? A randomised clinical trial.

Authors:  Hugo Sérgio de Oliveira Gomes; Heloisa de Sousa Gomes; Joji Sado-Filho; Luciane Rezende Costa; Paulo Sucasas Costa
Journal:  BMC Pediatr       Date:  2017-03-24       Impact factor: 2.125

6.  Minimum Alveolar Concentration of Sevoflurane with Cisatracurium for Endotracheal Intubation in Neonates.

Authors:  Bin Zhang; Junxia Wang; Mingzhuo Li; Feng Qi
Journal:  Med Sci Monit       Date:  2019-10-24

7.  Long Term Neurodevelopmental Outcomes after Sevoflurane Neonatal Exposure of Extremely Preterm Children: A Cross-Sectional Observationnal Study.

Authors:  Véronique Brévaut-Malaty; Noémie Resseguier; Aurélie Garbi; Barthélémy Tosello; Laurent Thomachot; Renaud Vialet; Catherine Gire
Journal:  Children (Basel)       Date:  2022-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.